Amedisys Inc AMED reports its Q4 adjusted EPS at $0.95, versus the consensus of $0.90. AMED reports its Q4 revenue at $394.3 million, versus the consensus of $399.58 million.
AMED shares fell 0.02% to $38.07 in after-hours trading.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
